Abstract
References
1.
Jandeleit-Dahm K.
,
Cao Z.
,
Cox A.J.
Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int 1999 ; 71 (suppl): S31 –6
2.
Inman S.R.
,
Stowe N.T.
,
Cressman M.D.
Lovastatin preserves renal function in experimental diabetes. Am J Med Sci 1999 ; 317 : 215 –21
3.
Yukawa S.
,
Mune M.
,
Yamada Y.
,
Otani H.
,
Kishino M.
,
Tone Y.
Ongoing clinical trials of lipid reduction therapy in patients with renal disease. Kidney Int 1999 ; 71 (suppl): S141 –3
4.
Lam K.S.
,
Cheng J.K.
,
Janus E.D.
,
Pang RW.
Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995 ; 38 : 604 –9
5.
Fried L.F.
,
Orchard T.J.
,
Kasiske BL.
Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001 ; 59 : 260 –9